Utilization of Blood Spot Testing for Metabolic-Genetic Disorders in Honduras: Is it Time for Newborn Screening?

Abstract

Honduran infant mortality (20/1000) has fallen below the Latin American newborn screening target rate (<30/1000). The authors report 2 Honduran maple syrup urine disease cases and a newborn screening pilot study. The first infant, diagnosed by plasma/urine testing in the U.S., prompted this study. Although marked clinical/radiological improvement occurred after treatment, moderate neurodevelopmental delays persist at 5 years. This 1-month, prospective study used blood spot specimens from hospitalized term Honduran neonates shipped overnight to South Carolina for routine newborn screening with electronic result submission to Honduras for follow-up. Of 88 consecutive neonates (mean age: 4.2 days, standard deviation: 4.2 days) tested, 24 (0.6%) of 3837 completed tests were positive. Another infant with maple syrup urine disease, diagnosed after study completion by blood spot testing, later died. The study findings indicate that collaborative blood spot testing aids in the diagnosis of Honduran metabolic-genetic disease. Newborn screening is now needed to diagnose and treat these diseases before morbidity/mortality develops.

Keywords

newborn screening Honduras blood spots genetic diseases inborn errors of metabolism neonatal congenital

Get full access to this article

View all access options for this article.

References

Borrajo GJC Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis. 2007; 30(4):466-481.

Solanki KK Training programmes for developing countries. J Inherit Metab Dis. 2007;30(4):596-599.

Christianson A. , Howson CP , Modell B. March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children. White Plains, New York, NY: March of Dimes Birth Defects Foundation; 2006.

The United Nations Children’s Fund. The State of the World’s Children 2007. New York, NY: UNICEF; 2009. www.unicef.org/infobycountry/honduras.html. Accessed May 6, 2009.

Penchaszadeh VB , Beiguelman B. Medical genetic services in Latin America: report of a meeting of experts. Rev Panam Salud Publica . 1998;3(6):409-420.

Holden KR , Collins JS , Greene JF , et al. Dietary intake and blood folate levels in Honduran women of childbearing age. J Child Neurol. 2002;17(5):341-346.

Guthrie R. , Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338-343.

Andermann A. , Blancquaert I. , Beauchamp S. , Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86(4):317-319.

Alwan A. , Modell B. Recommendations for introducing genetics services in developing countries . Nat Rev Genet. 2003;4(1): 61-68.

10.

Ivers LC , Smith Fawzi MC , Mann J. , Jerome JG , Raymonville M. , Mukherjee JS Overseas processing of dried blood spots for timely diagnosis of HIV in Haitian infants. Rev Panam Salud Publica. 2008;24(5):331-335.

11.

Mbah N. Telephone use for surgical follow-up in a developing country. Niger J Clin Pract. 2007;10(3):266.

12.

Ekele B. Strategies to improve patients follow-up in developing countries. Niger J Clin Pract. 2008;11(2):176.

13.

International Telecommunication Union. ICT and Telecommunications in the Least Developed Countries: Mid-term Review for the Decade 2001-2010. Geneva, Switzerland; 2006. http://www.itu.int/ITU-D/ldc/un-conference.html . Accessed May 6, 2009.

14.

Perkins RB , Langrish S. , Stern LJ , Simon CJ A community-based education program about cervical cancer improves knowledge and screening behavior in Honduran women. Rev Panam Salud Publica. 2007;22(3):187-193.

15.

Vela M. , Gamboa S. , Loera-Luna A. , Aguirre BE , Pérez-Palacios G. , Velázquez A. Neonatal screening for congenital hypothyroidism in Mexico: experience, obstacles, and strategies. J Med Screen. 1999 ;6(2):77-79.

16.

Morris SS , Flores R. , Olinto P. , Medina JM Monetary incentives in primary health care and effects on use and coverage of preventive health care interventions in rural Honduras: cluster randomized trial. Lancet. 2004;364(9450): 2030-2037.

17.

de Céspedes C. , Saborío M. , Trejos R. , Abarca G. , Sánchez A. , Rojas L. Evolution and innovations of the national neonatal and high risk screening program in Costa Rica. Rev Biol Trop. 2004;52(3):451-466.

18.

Lindner M. , Abdoh G. , Fang-Hoffmann J. , et al. Implementation of extended neonatal screening and a metabolic unit in the State of Qatar: developing and optimizing strategies in cooperation with the Neonatal Screening Center in Heidelberg. J Inherit Metab Dis. 2007;30(4):522-529.

19.

Therrell BL Challenges and opportunities in establishing and maintaining newborn screening systems. Southeast Asian J Trop Med Public Health. 2003;34(suppl 3):6-12.

20.

Olusanya BO Promoting effective interventions for neglected health conditions in developing countries. Disabil Rehabil . 2007;29(11-12):973-976.

21.

Bulyzhenkov V. Prevention and control of phenylketonuria . Bull World Health Organ. 1991;69(3):367-368.